Novo Nordisk NVO new weightloss PILL success
22% loss of bodyweight in 36 weeks.
Shares rose 13.5% to USD91.25 in premarket so far. 13:00 UTC+2.
22% loss of bodyweight in 36 weeks.
Shares rose 13.5% to USD91.25 in premarket so far. 13:00 UTC+2.